1. Home
  2. WGSWW vs ATLCP Comparison

WGSWW vs ATLCP Comparison

Compare WGSWW & ATLCP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • WGSWW
  • ATLCP
  • Stock Information
  • Founded
  • WGSWW 2017
  • ATLCP N/A
  • Country
  • WGSWW United States
  • ATLCP United States
  • Employees
  • WGSWW 1000
  • ATLCP 417
  • Industry
  • WGSWW Retail: Computer Software & Peripheral Equipment
  • ATLCP Finance: Consumer Services
  • Sector
  • WGSWW Technology
  • ATLCP Finance
  • Exchange
  • WGSWW Nasdaq
  • ATLCP Nasdaq
  • Market Cap
  • WGSWW N/A
  • ATLCP N/A
  • IPO Year
  • WGSWW N/A
  • ATLCP N/A
  • Fundamental
  • Price
  • WGSWW $0.09
  • ATLCP N/A
  • Analyst Decision
  • WGSWW
  • ATLCP
  • Analyst Count
  • WGSWW 0
  • ATLCP
  • Target Price
  • WGSWW N/A
  • ATLCP N/A
  • AVG Volume (30 Days)
  • WGSWW 36.6K
  • ATLCP N/A
  • Earning Date
  • WGSWW 02-18-2025
  • ATLCP 10-31-2025
  • Dividend Yield
  • WGSWW N/A
  • ATLCP N/A
  • EPS Growth
  • WGSWW N/A
  • ATLCP N/A
  • EPS
  • WGSWW N/A
  • ATLCP N/A
  • Revenue
  • WGSWW $305,450,000.00
  • ATLCP N/A
  • Revenue This Year
  • WGSWW N/A
  • ATLCP N/A
  • Revenue Next Year
  • WGSWW N/A
  • ATLCP N/A
  • P/E Ratio
  • WGSWW N/A
  • ATLCP N/A
  • Revenue Growth
  • WGSWW 50.79
  • ATLCP N/A
  • 52 Week Low
  • WGSWW $0.17
  • ATLCP N/A
  • 52 Week High
  • WGSWW $0.21
  • ATLCP N/A
  • Technical
  • Relative Strength Index (RSI)
  • WGSWW 57.06
  • ATLCP 47.31
  • Support Level
  • WGSWW $0.07
  • ATLCP $23.81
  • Resistance Level
  • WGSWW $0.12
  • ATLCP $24.01
  • Average True Range (ATR)
  • WGSWW 0.01
  • ATLCP 0.34
  • MACD
  • WGSWW 0.00
  • ATLCP -0.04
  • Stochastic Oscillator
  • WGSWW 48.36
  • ATLCP 55.55

About WGSWW GeneDx Holdings Corp.

GeneDx Holdings Corp delivers personalized and actionable health insights to inform diagnosis, direct treatment and improve drug discovery. The company is uniquely positioned to accelerate the use of genomic and large-scale clinical information to enable precision medicine as the standard of care. The company is at the forefront of transforming healthcare through its various exome and genome testing and interpretation, fueled by one of the world's substantial rare disease data sets.

About ATLCP Atlanticus Holdings Corporation 7.625% Series B Cumulative Perpetual Preferred Stock no par value per share

Atlanticus Holdings Corp invests in the financial services industry. It provides various credit and related financial services and products to or associated with the financially underserved consumer credit market. The operating business segments are the Credit as a Service (CaaS) and the Auto Finance segment. It generates maximum revenue from the Credit as a Service segment.

Share on Social Networks: